Sara Manglaviti
Crema, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies.
Journal: Cancer treatment reviews
Published: September 23, 2025
Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 27, 2024
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME).
Journal: Cancers
Published: November 19, 2024
Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].
Journal: Critical reviews in oncology/hematology
Published: September 24, 2024
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.
Journal: Tumori
Published: April 16, 2024
Unleashing precision: A review of targeted approaches in pleural mesothelioma.
Journal: Critical reviews in oncology/hematology
Published: February 11, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2023
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 09, 2023
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Journal: Clinical lung cancer
Published: April 25, 2023
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
Journal: Journal for immunotherapy of cancer
Published: April 09, 2023
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Journal: Clinical lung cancer
Published: April 06, 2023
Last Updated: 09/26/2026